How effective are continuous flow left ventricular assist devices in lowering high pulmonary artery pressures in heart transplant candidates?

Cardiology Journal

Volumn 19, Issue 2, 2012, Pages 153-158

  Pauwaa, Sunil ^a   Bhat, Geetha ^a   Tatooles, Antone J ^a   Aggarwal, Ashim ^a   Martin, Michele ^a   Kumar, Anup ^a   Modi, Harshit ^a   Pappas, Pat S ^a  

^a ADVOCATE CHRIST MEDICAL CENTER   (United States)

Author keywords

Continuous flow; Left ventricular assist devices; Pulmonary hypertension; Transplant

Indexed keywords

DOBUTAMINE; GLYCERYL TRINITRATE; MILRINONE; SILDENAFIL;

ADULT; ARTERIAL OXYGEN SATURATION; ARTICLE; CLINICAL ARTICLE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART TRANSPLANTATION; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PRESSURE GRADIENT; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; AGED; ARTERIAL PRESSURE; COMPARATIVE STUDY; HEART ASSIST DEVICE; HEART LEFT VENTRICLE FUNCTION; PATHOPHYSIOLOGY; PROSTHESIS; PULMONARY ARTERY; TIME; TREATMENT OUTCOME; VASCULAR RESISTANCE;

ADULT; AGED; ARTERIAL PRESSURE; FEMALE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROSTHESIS DESIGN; PULMONARY ARTERY; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, LEFT;

EID: 84879501341     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/CJ.2012.0027     Document Type: Article

References (37)

1. Mehra MR, Kobashigawa J, Starling R et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant, 2006; 25: 1024-1042.
2. Butler J, Stankewicz MA, Wu J et al. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J Heart Lung Transplant, 2005; 24: 170-177.
3. Klotz S, Deng MC, Hanafy D et al. Reversible pulmonary hypertension in heart transplant candidates-pretransplant evaluation and outcome after orthotopic heart transplantation. Eur J Heart Fail, 2003; 5: 645-653.
4. Delgado JF, Gomez-Sanches MA, Saenz de la Calzada C. Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. J Heart Lung Transplant, 2001; 20: 942-948.
5. Murali S, Kormos RL, Uretsky BF et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: The Pittsburgh experience. Am Heart J, 1993; 126: 896-904.
6. Erickson KW, Costanzo-Nordin MR, O'Sullivan EJ et al. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant, 1990; 9: 526-537.
7. Stobierska-Dzierzek B, Awad H, Michler RE. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol, 2001; 38: 923-931.
8. Torres Macho J, Delgado Jimenez JF, Sans Salvo J et al. Effect of different pharmacologic agents to reverse severe pulmonary hypertension among end-stage heart failure patients. Transplant Proc, 2009; 41: 2477-2479.
9. Pamboukian SV, Carere RG, Webb JG et al. The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension. J Heart Lung Transplant, 1999; 18: 367-371.
10. Zakliczynski M, Maruszewski M, Pyka L et al. Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates. Transplant Proc, 2007; 39: 2856-2858.
11. Hoeper MM, Barberà JA, Channick RN et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol, 2009; 54: S85-S96.
12. McLaughlin VV, Archer SL, Badesch DB, Barst RJ. ACCF/AHA 2009 expert consensus document on pulmonary hypertension. A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. J Am Coll Cardiol, 2009; 53: 1573-1619.
13. Moraes DL, Colucci WS, Givertz MM. Secondary pulmonary hypertension in chronic heart failure: The role of the endothelium in pathophysiology and management. Circulation, 2000; 102: 1718-1723.
14. Gehlbach BK, Geppert E. The pulmonary manifestations of left heart failure. Chest, 2004; 125: 669-682.
15. Nair PK, Kormos RL Teuteberg JJ et al. Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension. J Heart Lung Transplant, 2010; 29: 201-208.
16. Torre-Amione G, Southard R, Loebe M et al. Reversal of secondary pulmonary hypertension by axial and pulsatile mechani cal circulatory support. J Heart Lung Transplant, 2010; 29: 195--200.
17. Zimpfer D, Zrunek P, Roethy W et al. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg, 2007; 133: 689-695.
18. Etz CD, Welp HA, Tjan T et al. Medically refractory pulmonary hypertension: Treatment with nonpulsatile left ventricular assist devices. Ann Thorac Surg, 2007; 83: 1697-1705.
19. Salzberg SP, Lachat ML, von Harbou K, Zünd G, Turina MI. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Eur J Cardiothorac Surg, 2005; 27: 222-225.
20. Libby P, Bonow R, Zipes DP, Mann DL eds. Braunwald's heart disease: A textbook of cardiovascular medicine. 8th Ed. WB Saunders, St. Louis, Mo. 2008: 443, 449-455.
21. Butler J, Chomsky DB, Wilson JR. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol, 1999; 34: 1802-1806.
22. Guglin M, Khan H. Pulmonary hypertension in heart failure. J Cardiac Fail, 2010; 16: 461-474.
23. Kjaergaard J, Akkan D, Iversen KK et al. Prognostic importance of pulmonary hypertension in patients with heart failure. Am J Cardiol, 2007; 99: 1146-1150.
24. Abramson SV, Burke JF, Kelly JJ, Jr et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med, 1992; 116: 888-895.
25. Rose EA, Gelijns AC, Moskowitz AJ et al. Long-term use of a left ventricular assist device for end-stage heart failure (REMATCH Trial Group). N Engl J Med, 2001; 345: 1435-1443.
26. Miller LW, Pagani FD, Russell SD et al. Use of a continuousflow device in patients awaiting heart transplantation. N Engl J Med, 2007; 357: 885-896.
27. Slaughter MS, Rogers JG, Milano CA et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med, 2009; 361: 2241-2251.
28. Adamson RM, Dembitsky WP, Jaski BE et al. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency. ASAIO J, 1997; 43: 365-369.
29. Al-Khaldi A, Ergina P, DeVarennes B, Lachappelle K, Cecere R. Left ventricular unloading in a patient with end-stage cardiomyopathy and medically unresponsive pulmonary hypertension. Artif Organs, 2004; 28: 158-160.
30. Gallagher RC, Kormos RL, Gasior T, Murali S, Griffith BP, Hardesty RL. Univentricular support results in reduction of pulmonary resistance and improved right ventricular function. ASAIO Trans, 1991; 37: M287-M288.
31. Smedira NG, Massad MG, Navia J et al. Pulmonary hypertension is not a risk factor for RVAD use and death after LVAS support. ASAIO J, 1996; 42: M733-M735.
32. Petrofski JA, Hoopes CW, Bashore TM, Russell SD, Milano CA. Mechanical ventricular support lowers pulmonary vascular resistance in a patient with congenital heart disease. Ann Thorac Surg, 2003; 75: 1005-1007.
33. Bhat G, Costea A. Reversibility of medically unresponsive pulmonary hypertension with nesiritide in a cardiac transplant recipient. ASAIO J, 2003; 49: 608-610.
34. Alba AC, Rao V, Ross H. Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients. J Heart Lung Transplant, 2010; 29: 1253-1258.
35. Martin J, Sigenthaler MP, Friesewinkel O et al. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study. Eur J Cardiothorac Surg, 2004; 25: 971-977.
36. Haft J, Armstrong W, Dyke DB et al. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation, 2007; 116: I8-I15.
37. Fitzpatrick JR, Frederick JR, Hsu VM et al. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant, 2008; 27: 1286-1292.